Osi Systems Inc OSIS
We take great care to ensure that the data presented and summarized in this overview for OSI SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSIS
View all-
Black Rock Inc. New York, NY2.61MShares$592 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$479 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.23MShares$280 Million0.14% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL877KShares$199 Million0.04% of portfolio
-
State Street Corp Boston, MA727KShares$165 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA674KShares$153 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX591KShares$134 Million0.03% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0461KShares$105 Million0.45% of portfolio
-
Credit Suisse Ag Zurich, V8385KShares$87.4 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA379KShares$85.9 Million0.01% of portfolio
Latest Institutional Activity in OSIS
Top Purchases
Top Sells
About OSIS
OSI Systems, Inc. designs and manufactures electronic systems and components worldwide. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems, AS&E, and Gatekeeper names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.
Insider Transactions at OSIS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2025
|
Cary M. Okawa CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31
+1.25%
|
$4,340
$140.61 P/Share
|
Jun 30
2025
|
Ajay Mehra PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
$10,500
$140.61 P/Share
|
Jun 30
2025
|
Victor S Sze GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.1%
|
$10,500
$140.61 P/Share
|
Jun 30
2025
|
Alan I Edrick EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.03%
|
$10,500
$140.61 P/Share
|
Jun 30
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.02%
|
$10,500
$140.61 P/Share
|
Jun 30
2025
|
Paul Keith Morben PRES., OPTOELECTRONICS DIV |
BUY
Grant, award, or other acquisition
|
Direct |
75
+0.75%
|
$10,500
$140.61 P/Share
|
Jun 12
2025
|
Meyer/ Luskin |
SELL
Open market or private sale
|
Indirect |
1,000
-8.19%
|
$237,000
$237.15 P/Share
|
May 21
2025
|
William Francis Ballhaus Jr |
SELL
Open market or private sale
|
Indirect |
750
-3.02%
|
$171,000
$228.88 P/Share
|
May 16
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
SELL
Bona fide gift
|
Direct |
8,850
-2.61%
|
-
|
May 13
2025
|
Alan I Edrick EVP & CFO |
SELL
Open market or private sale
|
Direct |
20,000
-6.56%
|
$4,580,000
$229.0 P/Share
|
May 08
2025
|
Glenn Grindstaff CHIEF HUMAN RESOURCES OFFICER |
SELL
Open market or private sale
|
Direct |
688
-7.61%
|
$154,112
$224.89 P/Share
|
May 06
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
5,000
-100.0%
|
$1,100,000
$220.11 P/Share
|
May 06
2025
|
William Francis Ballhaus Jr |
SELL
Open market or private sale
|
Indirect |
933
-3.63%
|
$204,327
$219.77 P/Share
|
May 05
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
20,000
-5.56%
|
$4,420,000
$221.79 P/Share
|
Apr 23
2025
|
W Paul Constantine PRES., SPACELABS HEALTHCARE |
BUY
Grant, award, or other acquisition
|
Direct |
924
+50.0%
|
$174,636
$189.42 P/Share
|
Feb 19
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
SELL
Bona fide gift
|
Direct |
5,000
-1.37%
|
-
|
Feb 10
2025
|
William Francis Ballhaus Jr |
SELL
Bona fide gift
|
Indirect |
750
-2.83%
|
-
|
Feb 04
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
20,000
-5.2%
|
$3,960,000
$198.26 P/Share
|
Feb 03
2025
|
Deepak Chopra EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
20,000
-4.94%
|
$3,860,000
$193.55 P/Share
|
Jan 30
2025
|
Paul Keith Morben PRES., OPTOELECTRONICS DIV |
SELL
Open market or private sale
|
Direct |
155
-1.51%
|
$30,845
$199.36 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 272K shares |
---|
Payment of exercise price or tax liability | 140K shares |
---|---|
Bona fide gift | 41.3K shares |
Open market or private sale | 189K shares |